Bessemer Group
IBB icon

Bessemer Group’s iShares Biotechnology ETF IBB Stock Holding History

Bessemer Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Sell
829
-46
-5% -$7.87K ﹤0.01% 1467
2025
Q4 		$148K Buy
875
+39
+5% +$6.33K ﹤0.01% 1417
2025
Q3 		$121K Sell
836
-364
-30% -$49.7K ﹤0.01% 1239
2025
Q2 		$152K Sell
1,200
-1,875
-61% -$230K ﹤0.01% 1144
2025
Q1 		$393K Hold
3,075
– – ﹤0.01% 936
2024
Q4 		$407K Buy
3,075
+2,130
+225% +$299K ﹤0.01% 933
2024
Q3 		$138K Buy
945
+720
+320% +$104K ﹤0.01% 1207
2024
Q2 		$31K Buy
+225
New +$30K ﹤0.01% 1334
2024
Q1 		– Sell
-500
Closed -$68K – 2111
2023
Q4 		$68K Hold
500
– – ﹤0.01% 1283
2023
Q3 		$61K Hold
500
– – ﹤0.01% 1306
2023
Q2 		$63K Hold
500
– – ﹤0.01% 1330
2023
Q1 		$65K Hold
500
– – ﹤0.01% 1165
2022
Q4 		$66K Hold
500
– – ﹤0.01% 1107
2022
Q3 		$58K Buy
500
+200
+67% +$24.8K ﹤0.01% 1140
2022
Q2 		$35K Sell
300
-394,287
-100% -$46.8M ﹤0.01% 1157
2022
Q1 		$51.4M Buy
394,587
+394,287
+131,429% +$51.4M 0.11% 175
2021
Q4 		$46K Hold
300
– – ﹤0.01% 1144
2021
Q3 		$49K Sell
300
-344
-53% -$57.9K ﹤0.01% 1056
2021
Q2 		$105K Sell
644
-188
-23% -$29K ﹤0.01% 939
2021
Q1 		$125K Sell
832
-1,194
-59% -$190K ﹤0.01% 853
2020
Q4 		$307K Buy
2,026
+644
+47% +$92K ﹤0.01% 635
2020
Q3 		$187K Hold
1,382
– – ﹤0.01% 743
2020
Q2 		$189K Hold
1,382
– – ﹤0.01% 1154
2020
Q1 		$149K Hold
1,382
– – ﹤0.01% 1054
2019
Q4 		$167K Hold
1,382
– – ﹤0.01% 1106
2019
Q3 		$138K Sell
1,382
-460
-25% -$48.2K ﹤0.01% 1123
2019
Q2 		$201K Buy
1,842
+1,170
+174% +$124K ﹤0.01% 1078
2019
Q1 		$75K Sell
672
-948
-59% -$104K ﹤0.01% 1200
2018
Q4 		$156K Buy
1,620
+114
+8% +$12.1K ﹤0.01% 1043
2018
Q3 		$183K Hold
1,506
– – ﹤0.01% 1004
2018
Q2 		$165K Buy
1,506
+84
+6% +$8.98K ﹤0.01% 1020
2018
Q1 		$152K Sell
1,422
-150
-10% -$16.6K ﹤0.01% 1053
2017
Q4 		$168K Sell
1,572
-3,000
-66% -$321K ﹤0.01% 1045
2017
Q3 		$508K Sell
4,572
-150
-3% -$16K ﹤0.01% 843
2017
Q2 		$488K Buy
4,722
+1,050
+29% +$103K ﹤0.01% 867
2017
Q1 		$359K Sell
3,672
-135,300
-97% -$13M ﹤0.01% 955
2016
Q4 		$12.3M Buy
138,972
+138,300
+20,580% +$12.6M 0.06% 203
2016
Q3 		$65K Sell
672
-36
-5% -$3.42K ﹤0.01% 1172
2016
Q2 		$61K Sell
708
-570
-45% -$51.1K ﹤0.01% 832
2016
Q1 		$111K Buy
1,278
+606
+90% +$54.2K ﹤0.01% 768
2015
Q4 		$76K Sell
672
-393
-37% -$42.7K ﹤0.01% 888
2015
Q3 		$108K Sell
1,065
-201
-16% -$24.1K ﹤0.01% 828
2015
Q2 		$156K Hold
1,266
– – ﹤0.01% 783
2015
Q1 		$145K Buy
+1,266
New +$140K ﹤0.01% 777
2013
Q3 		– Sell
-627
Closed -$36K – 1297
2013
Q2 		$36K Buy
+627
New +$36.2K ﹤0.01% 823

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bessemer Group's IBB Position: Q1 2026 in Review

Bessemer Group reduced its iShares Biotechnology ETF (IBB) stake by 5.3% in Q1 2026, selling an estimated $7.87K and leaving 829 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Bessemer Group first reported a position in IBB in Q2 2013 and has held it in 45 quarters since. The position peaked at $51.4M in Q1 2022. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Bessemer Group held 829 shares of iShares Biotechnology ETF worth $140K as of Q1 2026.
  • Bessemer Group sold 46 iShares Biotechnology ETF shares in Q1 2026, an estimated $7.87K.
  • iShares Biotechnology ETF made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1467 holding.
  • Bessemer Group first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 45 quarters since.
  • Bessemer Group's iShares Biotechnology ETF position peaked at $51.4M in Q1 2022.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.